Video Library

Bone health is an important part of long-term recovery after bone marrow transplant and CAR T-cell therapy. This presentation explains why transplant recipients are at increased risk for bone loss and fractures, how osteoporosis develops, who should be screened, and what lifestyle changes, nutritional strategies, exercise, and medications can help maintain healthy bones and reduce fracture risk as patients age.

This presentation discusses quality of life after CAR T-cell therapy, potential short-term, late, and long-term side effects, incidence and risk factors for late and long-term side effects, how to monitor yourself for side effects, when and to whom you should report symptoms, and lifestyle changes that can help prevent or manage long-term effects of CAR T-cell therapy.

This presentation provides a detailed explanation of what an autologous stem cell transplant is, who is a good candidate, the steps involved in undergoing an autologous transplant, short- and long-term side effects, and steps survivors can take to maximize their quality of life after transplant.

Graft-versus-host disease (GVHD) is a side effect that can occur after an allogeneic bone marrow/stem cell transplant (a transplant using donor cells). This presentation discusses what GVHD is, how it can affect the gastrointestinal (GI) tract, risk factors for developing GI GVHD, symptoms of GI GVHD, treatment options, and strategies patients can use to minimize symptoms and improve outcomes after GI GVHD.

Monitoring and maintaining oral health after transplant is an important part of recovery. This presentation describes typical issues with oral health after transplant, including graft-versus-host disease, and how to treat these conditions effectively.

Transplant recipients often experience ongoing issues from their disease and treatment. This presentation describes typical post-transplant complications and how a survivorship plan can help survivors maintain optimal health.

Graft-versus-host disease (GVHD) is a potential complication after a bone marrow/stem cell transplant using donor cells. This presentation explains what GVHD (GVHD) is, the difference between acute and chronic GVHD, risk factors for developing GVHD, how to monitor yourself to catch and report symptoms early, treatment options, and lifestyle changes that can improve GVHD symptoms.

This presentation explores the connection between food, the gut microbiome, and chronic disease, introducing a framework called the microbiome-mitochondria axis. Dr. Damman explains how modern, ultra-processed foods strip away key bioactive components—fibers, phytonutrients, bioactive fats, and ferments (the "four Fs")—that the microbiome depends on to produce molecules essential for mitochondrial and overall cellular health. He also addresses nutrition-related questions specific to the transplant community, including fiber tolerance, fermented foods, probiotics, and GI symptom management.

Transcription: 00:03 (Marla): Welcome to the workshop, The Present and Future of CAR T-Cell Therapy. My name is Marla, and I will be your moderator for this workshop. Before we

In this session, leading experts on graft-versus-host disease (GVHD), a common complication after a bone marrow/stem cell transplant, respond to questions about who is at risk of developing GVHD, symptoms of GVHD, and how to manage both the physical and emotional problems associated with GVHD and its treatment.

This session features leading experts in CAR T-cell therapy for lymphoma and multiple myeloma, and a social worker who helps CAR T patients manage psychosocial and financial challenges during and after treatment. They discuss current CAR T therapies available for myeloma and lymphoma patients, side effects and outcomes after CAR T-cell therapy, and new CAR T products on the horizon.

This presentation provides an overview of various long-term effects that may occur after an autologous stem cell transplant, and provides strategies and advice for how these effects might be managed.